Amid a surge in healthcare deals globally last year including those backed by private equity, Asia Pacific’s disclosed deal value surged to $7.2 billion, with 61 deals in 2017 as compared to 52 in 2016, the highest level since 2001 and the momentum is expected to continue this year, according to a report from Bain & Company.